Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,050 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Platinum-based regimens versus cetuximab in definitive chemoradiation for human papillomavirus-unrelated head and neck cancer.
Beckham TH, Barney C, Healy E, Wolfe AR, Branstetter A, Yaney A, Riaz N, McBride SM, Tsai CJ, Kang J, Yu Y, Chen L, Sherman E, Dunn L, Pfister DG, Tan J, Rupert R, Bonomi M, Zhang Z, Lobaugh SM, Grecula JC, Mitchell DL, Wobb JL, Miller ED, Blakaj DM, Diavolitsis VM, Lee N, Bhatt AD. Beckham TH, et al. Among authors: dunn l. Int J Cancer. 2020 Jul 1;147(1):107-115. doi: 10.1002/ijc.32736. Epub 2019 Nov 11. Int J Cancer. 2020. PMID: 31609479 Free article.
Reply to B. O'Sullivan et Al.
Pfister DG, Baxi SS, Dunn LA, Fury MG. Pfister DG, et al. J Clin Oncol. 2015 May 20;33(15):1710. doi: 10.1200/JCO.2014.60.3563. Epub 2015 Mar 30. J Clin Oncol. 2015. PMID: 25823736 No abstract available.
Unmet needs for patients with salivary gland cancer.
Dunn LA, Ho AL, Laurie SA, Pfister DG. Dunn LA, et al. Oral Oncol. 2016 Sep;60:142-5. doi: 10.1016/j.oraloncology.2016.06.003. Epub 2016 Jul 1. Oral Oncol. 2016. PMID: 27377424 No abstract available.
Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques.
Leeman JE, Li JG, Pei X, Venigalla P, Zumsteg ZS, Katsoulakis E, Lupovitch E, McBride SM, Tsai CJ, Boyle JO, Roman BR, Morris LGT, Dunn LA, Sherman EJ, Lee NY, Riaz N. Leeman JE, et al. JAMA Oncol. 2017 Nov 1;3(11):1487-1494. doi: 10.1001/jamaoncol.2017.0973. JAMA Oncol. 2017. PMID: 28542679 Free PMC article.
Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid Cancers.
Dunn LA, Sherman EJ, Baxi SS, Tchekmedyian V, Grewal RK, Larson SM, Pentlow KS, Haque S, Tuttle RM, Sabra MM, Fish S, Boucai L, Walters J, Ghossein RA, Seshan VE, Ni A, Li D, Knauf JA, Pfister DG, Fagin JA, Ho AL. Dunn LA, et al. J Clin Endocrinol Metab. 2019 May 1;104(5):1417-1428. doi: 10.1210/jc.2018-01478. J Clin Endocrinol Metab. 2019. PMID: 30256977 Free PMC article.
1,050 results